Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #104624
advertisement
Xiu W
22
Showing records 1 to 22 |
Display all abstracts from
Xiu W
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Wang Z
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Yuan H
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Guo S
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Li A; Chen L
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
He C; Chen L
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Wang Z
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Wang J
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Zhu X
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Xiu W
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Wang J; Xiu W
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Zhang G
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Chen Y
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Chen Y; Li A
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Zhang G
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Zhu X
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Liu D; Xiao X
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Xiao X
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Sun C
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Yu L
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Lu F
Biomarkers in medicine
2024; 18: 545-553
119080
Increased Intestinal Inflammation and Permeability in Glaucoma
Lu F
Journal of inflammation research
2024; 17: 6895-6904
119379
α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Hu L; He C
Biomarkers in medicine
2024; 18: 545-553
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept